Press release
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting
CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the
About this update from Organogenesis Holdings Inc.
[{"type":"text","content":"CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, and Nushield® product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society Virtual Experience, held May 10-14. As a Platinum Sponsor for this year's conference, Organogenesis will present an Innovation Theater titled \"Clinical Evidence Outlines the Need for Early Advanced Standard of Care with Real-world Chronic Case Reviews\" on Friday, May 14 from 12:20 –1:20 p.m. ET. Led by Paula Pons, MD, CWSP, and Adam Teichman, DPM, FACFAS, the presentation will discuss a Pooled Analysis of 434 wounds at 30 centers that supports the use of PuraPly® AM to advance wounds out of the inflammatory phase. The discussion will include presentations of real-world case reviews. Other research highlights include: A podium presentation, “Effect of Dehydrated Amnion Chorion Membranes on Mesenchymal Stem Cells In Vitro,” presented by Katrina Harmon, PhD. The presentation will take place on May 12 during Session 1C of the conference from 12-1 p.m. ET. A video presentation that will highlight the poster, “A Comparative Effectiveness Research Study of a Native Type I Collagen Matrix plus Polyhexamethylene Biguanide Antimicrobial and a Cryopreserved Cadaveric Skin Allograft for Use in Venous Leg Ulcers – A Non-Inferiority Analysis.” One of only 10 posters selected for exhibition during the Virtual Poster Grand Rounds session, the video presentation will be led by Mike Sabolinski, MD. The accredited session will take place on May 14 at 5:50 ET. Visitors to the Organogenesis virtual exhibit booth will have the opportunity to participate in a live Q&A with a Tissue Regeneration Specialist about the Company’s innovative product solutions. “Organogenesis’ rich heritage of trusted innovation is built on efficacy and ongoing investment in clinical and real-world data, as evidenced by this latest body of research supporting the use of our products across the spectrum of wound care,” said Patrick Bilbo, Chief Operating Officer at Org...